Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trafermin for periodontal tissue regeneration
NCT00734708Phase 3Completed
- Sponsor
- Kaken Pharmaceutical Co., Ltd.
- Start
- Aug 2008
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of trafermin in periodontitis, sponsored by Kaken Pharmaceutical Co., Ltd.. Started Aug 2008; status: completed.
02
Drugs
trafermin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT00734708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734708.